Condition (MeSH)
Uterine Perforation
ClinicalTrials.gov lists 3 trials for Uterine Perforation or a narrower condition beneath it. Bayer has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
3 sections measured, none recorded · 1 not measured yet · 1 not computed
3 of the 3 trials are tagged with Uterine Perforation itself; the rest are tagged with a narrower condition beneath it.
When did Uterine Perforation trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2020 | 1 |
| 2018 | 1 |
| 2006 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Uterine Perforation trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 3 |
How many Uterine Perforation trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Uterine Perforation trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Bayer | 1 |
Which serious adverse events do Uterine Perforation trials report? (4)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Venous thromboembolic event | 14 | 1 |
| Cerebrovascular Events | 10 | 1 |
| Myocardial infarction | 3 | 1 |
| Other arterial thromboembolic event | 1 | 1 |
Which publications cover Uterine Perforation? (21)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. | Contraception | 2015 | Yes |
| Hysteroscopic morcellation: review of the manufacturer and user facility device experience (MAUDE) database. | Journal of minimally invasive gynecology | 2015 | Yes |
| Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities. | Journal of pediatric and adolescent gynecology | 2014 | Yes |
| Ultrasound is the optimal choice for guidance in difficult hysteroscopy. | Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology | 2012 | Yes |
| Management of missing strings in users of intrauterine contraceptives. | Contraception | 2012 | Yes |
Showing 5 of 21 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.